Skip to content

A clinical study of the effect of cognitive-distraction-Attention-relaxation therapy based on MR On chronic spine-related pain: a single-center, randomized controlled, single-blind clinical study

A clinical study of the effect of cognitive-distraction-Attention-relaxation therapy based on MR On chronic spine-related pain: a single-center, randomized controlled, single-blind clinical study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097103
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific spinal related pain

Interventions

Group B (sham MR Group):Provide 2D treatment on TV screen with the same content as MR
Group A (pain key group):Mixed reality pain treatment software, pain treatment scenes in MR

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Men and women aged 18-80 years; 2.Patients with a clinical diagnosis of chronic spine-related pain; 3.Chronic pain lasting more than 3 months; 4.The average pain intensity in the past month is 4 points or above (BPI); 5.Willing to comply with the relevant regulations of the experiment; 6.Willing and able to sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Severe cognitive impairment; 2.A current or previous diagnosis of epilepsy, dementia, migraine, or other neurological disorder may hinder the use of mixed reality or have adverse effects; 3.Symptoms of nausea or dizziness; 4.Sensitive to light-emitting screens; 5.No stereoscopic vision or severe hearing impairment; 6.Injuries to the eyes, face or neck that prevent comfortable use of glasses.

Design outcomes

Primary

MeasureTime frame
Effective rate of pain relief;

Secondary

MeasureTime frame
Pain on Activity, Sleep, Stress and Mood Disturbance Scale (DVPRS-II);Effective in improving physiological function and sleep disorders;Effective in decrease pain catastrophize;incidence in screen vertigo;

Countries

China

Contacts

Public ContactXiao Hong

West China Hospital of Sichuan University

xiaohonghuaxi@126.com+86 28 85423226

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026